Novel drug shows early promise in treating multiple myeloma

A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania's Abramson Cancer Center at the 2022 American Society of Hematology (ASH) Annual Meeting.

source https://medicalxpress.com/news/2022-12-drug-early-multiple-myeloma.html